449 related articles for article (PubMed ID: 10218968)
1. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
Mountjoy KG; Willard DH; Wilkison WO
Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
[TBL] [Abstract][Full Text] [Related]
2. Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells.
Mountjoy KG; Kong PL; Taylor JA; Willard DH; Wilkison WO
Physiol Genomics; 2001 Feb; 5(1):11-9. PubMed ID: 11161002
[TBL] [Abstract][Full Text] [Related]
3. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line.
Boston BA; Cone RD
Endocrinology; 1996 May; 137(5):2043-50. PubMed ID: 8612546
[TBL] [Abstract][Full Text] [Related]
4. alpha-MSH and desacetyl-alpha-MSH signaling through melanocortin receptors.
Mountjoy KG; Wu CS; Cornish J; Callon KE
Ann N Y Acad Sci; 2003 Jun; 994():58-65. PubMed ID: 12851298
[TBL] [Abstract][Full Text] [Related]
5. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
[TBL] [Abstract][Full Text] [Related]
6. Agouti protein inhibits growth of B16 melanoma cells in vitro by acting through melanocortin receptors.
Siegrist W; Willard DH; Wilkison WO; Eberle AN
Biochem Biophys Res Commun; 1996 Jan; 218(1):171-5. PubMed ID: 8573126
[TBL] [Abstract][Full Text] [Related]
7. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
8. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.
Fan W; Boston BA; Kesterson RA; Hruby VJ; Cone RD
Nature; 1997 Jan; 385(6612):165-8. PubMed ID: 8990120
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of ligand binding to the melanocortin receptors.
Kiefer LL; Ittoop OR; Bunce K; Truesdale AT; Willard DH; Nichols JS; Blanchard SG; Mountjoy K; Chen WJ; Wilkison WO
Biochemistry; 1997 Feb; 36(8):2084-90. PubMed ID: 9047307
[TBL] [Abstract][Full Text] [Related]
10. Antagonist and agonist activities of the mouse agouti protein fragment (91-131) at the melanocortin-1 receptor.
Eberle AN; Bódi J; Orosz G; Süli-Vargha H; Jäggin V; Zumsteg U
J Recept Signal Transduct Res; 2001 Feb; 21(1):25-45. PubMed ID: 11693171
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the melanocyte stimulating hormones on food intake. Lack Of evidence to support a role for the melanocortin-3-receptor.
Abbott CR; Rossi M; Kim M; AlAhmed SH; Taylor GM; Ghatei MA; Smith DM; Bloom SR
Brain Res; 2000 Jun; 869(1-2):203-10. PubMed ID: 10865075
[TBL] [Abstract][Full Text] [Related]
12. Interaction of melanin-concentrating hormone (MCH), neuropeptide E-I (NEI), neuropeptide G-E (NGE), and alpha-MSH with melanocortin and MCH receptors on mouse B16 melanoma cells.
Hintermann E; Tanner H; Talke-Messerer C; Schlumberger S; Zumsteg U; Eberle AN
J Recept Signal Transduct Res; 2001 Feb; 21(1):93-116. PubMed ID: 11693176
[TBL] [Abstract][Full Text] [Related]
13. Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors.
Adan RA; Oosterom J; Ludvigsdottir G; Brakkee JH; Burbach JP; Gispen WH
Eur J Pharmacol; 1994 Nov; 269(3):331-7. PubMed ID: 7895772
[TBL] [Abstract][Full Text] [Related]
14. Effects of melanocortin receptor ligands on thyrotropin-releasing hormone release: evidence for the differential roles of melanocortin 3 and 4 receptors.
Kim MS; Small CJ; Russell SH; Morgan DG; Abbott CR; alAhmed SH; Hay DL; Ghatei MA; Smith DM; Bloom SR
J Neuroendocrinol; 2002 Apr; 14(4):276-82. PubMed ID: 11963824
[TBL] [Abstract][Full Text] [Related]
15. [Detection of binding activity and biologic effect of a novel alpha-melanocyte-stimulating hormone analogue].
Ying Y; Lan XP; Tian YP
Yao Xue Xue Bao; 2007 Mar; 42(3):269-73. PubMed ID: 17520825
[TBL] [Abstract][Full Text] [Related]
16. ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors.
Fong TM; Mao C; MacNeil T; Kalyani R; Smith T; Weinberg D; Tota MR; Van der Ploeg LH
Biochem Biophys Res Commun; 1997 Aug; 237(3):629-31. PubMed ID: 9299416
[TBL] [Abstract][Full Text] [Related]
17. Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin.
Martin NM; Small CJ; Sajedi A; Patterson M; Ghatei MA; Bloom SR
Int J Obes Relat Metab Disord; 2004 Jul; 28(7):886-93. PubMed ID: 15148507
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Agouti-related protein binding to melanocortin receptors.
Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
[TBL] [Abstract][Full Text] [Related]
19. Asp10 in Lys-gamma2-MSH determines selective activation of the melanocortin MC3 receptor.
Oosterom J; Burbach JP; Gispen WH; Adan RA
Eur J Pharmacol; 1998 Jul; 354(1):R9-11. PubMed ID: 9726642
[TBL] [Abstract][Full Text] [Related]
20. AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor.
Nijenhuis WA; Oosterom J; Adan RA
Mol Endocrinol; 2001 Jan; 15(1):164-71. PubMed ID: 11145747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]